261 related articles for article (PubMed ID: 30648870)
1. Metallo-Cubosomes: Zinc-Functionalized Cubic Nanoparticles for Therapeutic Nucleotide Delivery.
Tajik-Ahmadabad B; Chollet L; White J; Separovic F; Polyzos A
Mol Pharm; 2019 Mar; 16(3):978-986. PubMed ID: 30648870
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM).
Rizwan SB; Dong YD; Boyd BJ; Rades T; Hook S
Micron; 2007; 38(5):478-85. PubMed ID: 17011783
[TBL] [Abstract][Full Text] [Related]
3. Cuboplex-Mediated Nonviral Delivery of Functional siRNA to Chinese Hamster Ovary (CHO) Cells.
Sarkar S; Tran N; Soni SK; Nasa Z; Drummond CJ; Conn CE
ACS Appl Mater Interfaces; 2021 Jan; 13(2):2336-2345. PubMed ID: 33410653
[TBL] [Abstract][Full Text] [Related]
4. Microfluidics Synthesis of Gene Silencing Cubosomes.
Kim H; Sung J; Chang Y; Alfeche A; Leal C
ACS Nano; 2018 Sep; 12(9):9196-9205. PubMed ID: 30081623
[TBL] [Abstract][Full Text] [Related]
5. Glycerol monooleate-based nanocarriers for siRNA delivery in vitro.
Zhen G; Hinton TM; Muir BW; Shi S; Tizard M; McLean KM; Hartley PG; Gunatillake P
Mol Pharm; 2012 Sep; 9(9):2450-7. PubMed ID: 22794355
[TBL] [Abstract][Full Text] [Related]
6. Microcontainers as an oral delivery system for spray dried cubosomes containing ovalbumin.
Nielsen LH; Rades T; Boyd B; Boisen A
Eur J Pharm Biopharm; 2017 Sep; 118():13-20. PubMed ID: 27993733
[TBL] [Abstract][Full Text] [Related]
7. Size and phase control of cubic lyotropic liquid crystal nanoparticles.
Hartnett TE; Ladewig K; O'Connor AJ; Hartley PG; McLean KM
J Phys Chem B; 2014 Jul; 118(26):7430-9. PubMed ID: 24915497
[TBL] [Abstract][Full Text] [Related]
8. A systematic study of the effect of lipid architecture on cytotoxicity and cellular uptake of cationic cubosomes.
Pushpa Ragini S; Dyett BP; Sarkar S; Zhai J; White JF; Banerjee R; Drummond CJ; Conn CE
J Colloid Interface Sci; 2024 Jun; 663():82-93. PubMed ID: 38394820
[TBL] [Abstract][Full Text] [Related]
9. Monoolein Cubic Phase Gels and Cubosomes Doped with Magnetic Nanoparticles-Hybrid Materials for Controlled Drug Release.
Szlezak M; Nieciecka D; Joniec A; Pękała M; Gorecka E; Emo M; Stébé MJ; Krysiński P; Bilewicz R
ACS Appl Mater Interfaces; 2017 Jan; 9(3):2796-2805. PubMed ID: 28029248
[TBL] [Abstract][Full Text] [Related]
10. A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake.
Luo Q; Lin T; Zhang CY; Zhu T; Wang L; Ji Z; Jia B; Ge T; Peng D; Chen W
Int J Pharm; 2015 Sep; 493(1-2):30-9. PubMed ID: 26209071
[TBL] [Abstract][Full Text] [Related]
11. Solubilization of hydrophobic guest molecules in the monoolein discontinuous QL cubic mesophase and its soft nanoparticles.
Efrat R; Kesselman E; Aserin A; Garti N; Danino D
Langmuir; 2009 Feb; 25(3):1316-26. PubMed ID: 18781793
[TBL] [Abstract][Full Text] [Related]
12. Size-Dependent Encapsulation and Release of dsDNA from Cationic Lyotropic Liquid Crystalline Cubic Phases.
Sarkar S; Tran N; Soni SK; Conn CE; Drummond CJ
ACS Biomater Sci Eng; 2020 Aug; 6(8):4401-4413. PubMed ID: 33455184
[TBL] [Abstract][Full Text] [Related]
13. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
[TBL] [Abstract][Full Text] [Related]
14. Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles.
Zhai J; Waddington L; Wooster TJ; Aguilar MI; Boyd BJ
Langmuir; 2011 Dec; 27(24):14757-66. PubMed ID: 22026367
[TBL] [Abstract][Full Text] [Related]
15. Freeze-dried and re-hydrated liquid crystalline nanoparticles stabilized with disaccharides for drug-delivery of the plectasin derivative AP114 antimicrobial peptide.
Boge L; Västberg A; Umerska A; Bysell H; Eriksson J; Edwards K; Millqvist-Fureby A; Andersson M
J Colloid Interface Sci; 2018 Jul; 522():126-135. PubMed ID: 29587194
[TBL] [Abstract][Full Text] [Related]
16. Cubosomes for topical delivery of the antimicrobial peptide LL-37.
Boge L; Hallstensson K; Ringstad L; Johansson J; Andersson T; Davoudi M; Larsson PT; Mahlapuu M; Håkansson J; Andersson M
Eur J Pharm Biopharm; 2019 Jan; 134():60-67. PubMed ID: 30445164
[TBL] [Abstract][Full Text] [Related]
17. A QCM-D and SAXS Study of the Interaction of Functionalised Lyotropic Liquid Crystalline Lipid Nanoparticles with siRNA.
Tajik-Ahmadabad B; Mechler A; Muir BW; McLean K; Hinton TM; Separovic F; Polyzos A
Chembiochem; 2017 May; 18(10):921-930. PubMed ID: 28233412
[TBL] [Abstract][Full Text] [Related]
18. Synthetic ionizable aminolipids induce a pH dependent inverse hexagonal to bicontinuous cubic lyotropic liquid crystalline phase transition in monoolein nanoparticles.
Rajesh S; Zhai J; Drummond CJ; Tran N
J Colloid Interface Sci; 2021 May; 589():85-95. PubMed ID: 33450463
[TBL] [Abstract][Full Text] [Related]
19. Interaction between lamellar (vesicles) and nonlamellar lipid liquid-crystalline nanoparticles as studied by time-resolved small-angle X-ray diffraction.
Vandoolaeghe P; Barauskas J; Johnsson M; Tiberg F; Nylander T
Langmuir; 2009 Apr; 25(7):3999-4008. PubMed ID: 19714888
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo.
Shi X; Peng T; Huang Y; Mei L; Gu Y; Huang J; Han K; Li G; Hu C; Pan X; Wu C
Pharm Dev Technol; 2017 May; 22(3):322-329. PubMed ID: 26670780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
